Mandana Khalili

Summary

Affiliation: University of California
Country: USA

Publications

  1. pmc Impact of insulin resistance on HCV treatment response and impact of HCV treatment on insulin sensitivity using direct measurements of insulin action
    Danielle Brandman
    Department of Medicine, University of California San Francisco, San Francisco, California, USA
    Diabetes Care 35:1090-4. 2012
  2. pmc Formal patient education improves patient knowledge of hepatitis C in vulnerable populations
    Miranda Surjadi
    Department of Medicine, San Francisco General Hospital, University of California San Francisco, 1001 Potrero Ave, NH 3D, San Francisco, CA 94110, USA
    Dig Dis Sci 56:213-9. 2011
  3. pmc Hepatitis B and hepatocellular carcinoma screening among Asian Americans: survey of safety net healthcare providers
    Mandana Khalili
    Department of Medicine, University of California San Francisco, San Francisco General Hospital, 1001 Potrero Ave, NH 3D, San Francisco, CA 94110, USA
    Dig Dis Sci 56:1516-23. 2011
  4. ncbi request reprint Applicability, tolerability and efficacy of preemptive antiviral therapy in hepatitis C-infected patients undergoing liver transplantation
    Amandeep K Shergill
    Department of Medicine, University of California San Francisco, San Francisco, CA, USA
    Am J Transplant 5:118-24. 2005
  5. ncbi request reprint Methods for quantifying insulin resistance in human immunodeficiency virus-positive patients
    James W Chu
    Department of Medicine, Stanford University School of Medicine, CA, USA
    Metabolism 52:858-61. 2003
  6. ncbi request reprint Management of hepatitis C-infected liver transplant recipients at large North American centres: changes in recent years
    Mandana Khalili
    Department of Medicine, University of California, San Francisco, CA 94110, USA
    Clin Transplant 20:1-9. 2006
  7. ncbi request reprint Pegylated interferon alpha-2a with or without ribavirin in HCV/HIV coinfection: partially blinded, randomized multicenter trial
    Mandana Khalili
    University of California, San Francisco, San Francisco, California, USA
    Dig Dis Sci 50:1148-55. 2005
  8. ncbi request reprint Relative effects of insulin resistance and protease inhibitor treatment on lipid and lipoprotein metabolism in HIV-infected patients
    George Beatty
    Department of Medicine, University of California San Francisco at San Francisco General Hospital, San Francisco, California 94110, USA
    HIV Clin Trials 5:383-91. 2004
  9. ncbi request reprint Treatment of the hepatitis C virus in patients coinfected with HIV
    Mandana Khalili
    University of California, San Francisco, San Francisco General Hospital, 1001 Potrero Avenue, NH 3D, San Francisco, CA 94110, USA
    Gastroenterol Clin North Am 33:479-96, vii-viii. 2004
  10. ncbi request reprint New onset diabetes mellitus after liver transplantation: the critical role of hepatitis C infection
    Mandana Khalili
    Department of Medicine, University of California San Francisco, San Francisco, CA 94110, USA
    Liver Transpl 10:349-55. 2004

Collaborators

Detail Information

Publications15

  1. pmc Impact of insulin resistance on HCV treatment response and impact of HCV treatment on insulin sensitivity using direct measurements of insulin action
    Danielle Brandman
    Department of Medicine, University of California San Francisco, San Francisco, California, USA
    Diabetes Care 35:1090-4. 2012
    ....
  2. pmc Formal patient education improves patient knowledge of hepatitis C in vulnerable populations
    Miranda Surjadi
    Department of Medicine, San Francisco General Hospital, University of California San Francisco, 1001 Potrero Ave, NH 3D, San Francisco, CA 94110, USA
    Dig Dis Sci 56:213-9. 2011
    ..Vulnerable populations including IDUs are disproportionally affected by HCV. Effective HCV education can potentially reduce disparity in HCV prevalence and its outcome in this population...
  3. pmc Hepatitis B and hepatocellular carcinoma screening among Asian Americans: survey of safety net healthcare providers
    Mandana Khalili
    Department of Medicine, University of California San Francisco, San Francisco General Hospital, 1001 Potrero Ave, NH 3D, San Francisco, CA 94110, USA
    Dig Dis Sci 56:1516-23. 2011
    ..Physician patterns of screening for hepatitis B (HBV) and hepatocellular carcinoma (HCC) among Asian Americans are not well described...
  4. ncbi request reprint Applicability, tolerability and efficacy of preemptive antiviral therapy in hepatitis C-infected patients undergoing liver transplantation
    Amandeep K Shergill
    Department of Medicine, University of California San Francisco, San Francisco, CA, USA
    Am J Transplant 5:118-24. 2005
    ..Future studies should focus on alternative dosing schedules with more aggressive use of adjuvant therapies, including GFs...
  5. ncbi request reprint Methods for quantifying insulin resistance in human immunodeficiency virus-positive patients
    James W Chu
    Department of Medicine, Stanford University School of Medicine, CA, USA
    Metabolism 52:858-61. 2003
    ..43 to 0.61), thereby possessing limited ability to predict SSPG variability (r2=0.18 to 0.37). In conclusion, indirect measures of IMGU need to be applied with caution when evaluating insulin action in HIV-infected patients...
  6. ncbi request reprint Management of hepatitis C-infected liver transplant recipients at large North American centres: changes in recent years
    Mandana Khalili
    Department of Medicine, University of California, San Francisco, CA 94110, USA
    Clin Transplant 20:1-9. 2006
    ..We conclude that there is considerable variability in the management of HCV among transplant programs and over time...
  7. ncbi request reprint Pegylated interferon alpha-2a with or without ribavirin in HCV/HIV coinfection: partially blinded, randomized multicenter trial
    Mandana Khalili
    University of California, San Francisco, San Francisco, California, USA
    Dig Dis Sci 50:1148-55. 2005
    ..PegIFNalpha-2a was therefore at least as effective as standard interferon and ribavirin combination therapy and was well tolerated, without a negative impact on HIV parameters...
  8. ncbi request reprint Relative effects of insulin resistance and protease inhibitor treatment on lipid and lipoprotein metabolism in HIV-infected patients
    George Beatty
    Department of Medicine, University of California San Francisco at San Francisco General Hospital, San Francisco, California 94110, USA
    HIV Clin Trials 5:383-91. 2004
    ..The relationship between insulin resistance, dyslipidemia, HIV infection, and antiretroviral therapy remains unclear, and the atherogenic nature of lipid and lipoprotein profiles in HIV-infected patients has not been fully characterized...
  9. ncbi request reprint Treatment of the hepatitis C virus in patients coinfected with HIV
    Mandana Khalili
    University of California, San Francisco, San Francisco General Hospital, 1001 Potrero Avenue, NH 3D, San Francisco, CA 94110, USA
    Gastroenterol Clin North Am 33:479-96, vii-viii. 2004
    ..Moreover, interactions between HCV and HIV antiviral medications may occur and potentially affect treatment efficacy. Thus, the decision to undertake HCV treatment must be individualized...
  10. ncbi request reprint New onset diabetes mellitus after liver transplantation: the critical role of hepatitis C infection
    Mandana Khalili
    Department of Medicine, University of California San Francisco, San Francisco, CA 94110, USA
    Liver Transpl 10:349-55. 2004
    ..However, among those developing de novo persistent diabetes, HCV is one of the most important risk factors. This adds further support to the epidemiological data linking HCV and diabetes...
  11. ncbi request reprint Quantification of insulin-mediated glucose disposal in HIV-infected individuals: comparison of patients treated and untreated with protease inhibitors
    George Beatty
    Department of Medicine, University of California San Francisco, San Francisco General Hospital, San Francisco, California 94110, USA
    J Acquir Immune Defic Syndr 33:34-40. 2003
    ..Finally, PI treatment may have an inhibitory effect on insulin secretion...
  12. ncbi request reprint Hepatitis C in the setting of HIV co-infection
    Mandana Khalili
    University of California San Francisco, San Francisco General Hospital, 1001 Potrero Avenue, NH 3D, San Francisco, CA 94110, USA
    Microbes Infect 4:1247-51. 2002
    ..However, additional information is required to assess the efficacy and safety of HCV therapy including possible interaction of HCV and HIV anti-viral medications in these co-infected individuals...
  13. doi request reprint Long-term histological effects of preemptive antiviral therapy in liver transplant recipients with hepatitis C virus infection
    Alexander Kuo
    Division of Gastroenterology, University of California, San Diego, CA, USA
    Liver Transpl 14:1491-7. 2008
    ..004). We conclude that preemptive antiviral therapy in virologic nonresponders delays the time to subsequent HCV treatment and may confer a reduced risk of fibrosis progression. Further study of preemptive antiviral therapy is warranted...
  14. doi request reprint Comparison of surrogate and direct measurement of insulin resistance in chronic hepatitis C virus infection: impact of obesity and ethnicity
    Khoa D Lam
    Department of Medicine, University of California San Francisco, San Francisco, CA, USA
    Hepatology 52:38-46. 2010
    ..Repeat HOMA-IR measurements had higher within-person variation in the obese (standard deviation = 0.77 higher than normal-weight, 95% confidence interval = 0.25-1.30, P = 0.005)...
  15. ncbi request reprint Daily versus thrice-weekly interferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected persons: a multicenter randomized controlled trial
    Mark S Sulkowski
    Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
    J Acquir Immune Defic Syndr 35:464-72. 2004
    ..In conclusion, SVR was achieved in 19% of HIV/HCV coinfected subjects treated with daily IFN plus RBV, but the effectiveness of therapy was substantially diminished by relatively high rates of treatment-related toxicity...

Research Grants5

  1. Insulin Resistance in HCV Infection
    Mandana Khalili; Fiscal Year: 2006
    ..One of the important advantages of this study is that patients will be evaluated before and after HCV treatment. This will permit a direct evaluation of the causative role of HCV in promoting insulin resistance and hepatic steatosis. ..
  2. HCV-induced alterations in glucose metabolism
    Mandana Khalili; Fiscal Year: 2006
    ..The proposed studies will provide insight into the pathogenesis of diabetes in the setting of HCV because we will be able to directly evaluate alterations in glucose metabolism induced by HCV ..
  3. Impact of Hepatitis C on Insulin Sensitivity and Insulin Secretion in Latinos
    Mandana Khalili; Fiscal Year: 2009
    ....
  4. Impact of Hepatitis C on Insulin Sensitivity and Insulin Secretion in Latinos
    Mandana Khalili; Fiscal Year: 2010
    ....